Correction of remodeling and function of small arteries in human hypertension by cilazapril, an angiotensin I-converting enzyme inhibitor

Journal of Cardiovascular Pharmacology

Volumn 27, Issue SUPPL. 2, 1996, Pages

  Schiffrin, Ernesto L ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

Blood vessels; Essential hypertension; Vascular hypertrophy; Vascular remodeling; Blockers

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; BLOOD PRESSURE MONITORING; BLOOD VESSEL FUNCTION; BLOOD VESSEL TONE; CLINICAL ARTICLE; CONFERENCE PAPER; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; FEMALE; HEART VENTRICLE REMODELING; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; TREATMENT OUTCOME; VASODILATATION;

EID: 0029880432     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199600002-00004     Document Type: Conference Paper

References (31)

1. Bohlen HG. Localization of vascular resistance changes during hypertension. Hypertension 1986;8:181-3.
2. Mulvany MJ, Aalkjaer C. Structure and function of small arteries. Physiol Rev 1990;70:921-71.
3. Schiffrin EL. Reactivity of small blood vessels in hypertension. Relationship with structural changes. Hypertension 1992;19(suppl II):II-1-9.
4. Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJ. Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res 1987;61:181-6.
5. Schiffrin EL, Deng LY, Larochelle P. Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. Clin Invest Med 1993; 16:177-86.
6. Mulvany MJ, Halpern W. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977;41:19-26.
7. Mulvany MJ, Hansen PK, Aalkjaer C. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 1978;43:854-64.
8. Deng LY, Schiffrin EL. Morphologic and functional alterations of mesenteric small resistance arteries in early renal hypertension in the rat. Am J Physiol 1991;261:H1171-7.
9. Deng LY, Schiffrin EL. Effects of endothelin-1 and vasopressin on resistance arteries of spontaneously hypertensive rats. Am J Hypertens 1992;5:817-22.
10. Baumbach GL, Heistad DD. Remodeling of cerebral arterioles in chronic hypertension. Hypertension 1989;13:968-72.
11. Korsgaard N, Aalkjaer C, Heagerty AM, Izzard AS, Mulvany MJ. Histology of subcutaneous small arteries from patients with essential hypertension. Hypertension 1993;22: 523-6.
12. Schiffrin EL, Deng LY, Larochelle P. Blunted effects of endothelin upon small subcutaneous resistance arteries of mild essential hypertensive patients. J Hypertens 1992;10:437-44.
13. Lockette W, Otsuka Y, Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986;8(suppl 2):II-61-6.
14. 1 expression determines growth response to angiotensin II. J Clin Invest 1992;90:456-61.
15. Griffin SA, Brown WCB, Macpherson F, et al. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991;17:626-35.
16. Harrap SB, Van der Merwe WM, Griffin SA, McPherson F, Lever AF. Brief angiotensin converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure longterm. Hypertension 1990;16:603-14.
17. Mulvany MJ, Persson AEG, Andresen J. No persistent effect of angiotensin converting enzyme inhibitor treatment in Milan hypertensive rats despite regression of vascular structure. J Hypertens 1991;9:589-93.
18. Morton JJ, Beattie EC, MacPherson F. Angiotensin II receptor antagonist losartan has persistent effects on blood pressure in the young spontaneously hypertensive rat: lack of relation to vascular structure. J Vasc Res 1992;29:264-9.
19. Deng LY, Schiffrin EL. Effect of antihypertensive treatment on response to endothelin of resistance arteries of hypertensive rats. J Cardiovasc Pharmacol 1993;21:725-31.
20. Heagerty AM, Bund SJ, Aalkjaer C. Effects of drug treatment on resistance arteriole morphology in essential hypertension: direct evidence for structural remodelling of resistance vessels. Lancet 1988;2:1209-12.
21. Aalkjaer C, Eiskjaer H, Mulvany MJ, et al. Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment. J Hypertens 1989;7:305-10.
22. Schiffrin EL, Deng LY, Larochelle P. Effects of a beta blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. Hypertension 1994;23: 83-91.
23. Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta blocker. Am J Hypertens 1995;8:229-36.
24. Schiffrin EL, Deng LY. Comparison of effects of angiotensin I-converting enzyme inhibition and beta blockade on function of small arteries from hypertensive patients. Hypertension 1995;25(Part 2):699-703.
25. Clozel M. Mechanism of action of angiotensin converting enzyme inhibitors on endothelial function in hypertension. Hypertension 1991;18(suppl II):II-37-42.
26. Thybo NK, Stephens N, Cooper A, Aalkjaer C, Heagerty AM, Mulvany MJ. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995;25(Part 1):474-81.
27. Agabiti Rosei E, Rizzoni D, Castellano M, et al. Media:lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995;13: 349-55.
28. Adams MA, Bobik A, Korner PI. Enalapril can prevent vascular amplifier development in spontaneously hypertensive rats Hypertension 1990;16:252-60.
29. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-7.
30. Cockroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med 1994;330:1036-40.
31. Thybo NK, Korsgaard N, Eriksen S, Christensen KL, Mulvany MJ. Dose-dependent effects of perindopril on blood pressure and small-artery structure. Hypertension 1994;23: 659-66.